テキサスにおける関節リウマチの臨床試験
テキサス内の拠点で、関節リウマチに関する16件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Epic Medical Research /ID# 279180, Red Oak
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07607964RA-PRO PRAGMATIC TRIAL
- Heritage Rheumatology and Arthritis Care, Colleyville
- Southwest Medical Center, Dallas
- Texas Arthritis Center, PA, El Paso
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Tekton Research - West Gate /ID# 272270, Austin
- Trinity Universal Research Associates - Carrollton /ID# 272577, Carrollton
- Arthritis Care Of Texas /ID# 277961, Corpus Christi
- 他11件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06972446A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Precision Comprehensive Clinical Research Solutions, Colleyville
- Accurate Clinical Management, Houston
- DM Clinical Research, Tomball
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07137598An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- Accurate Clinical Management LLC, Houston
- DM Clinical Research, Tomball
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07620392Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, Allen
- Research Site, Mesquite
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/09/18更新 · NCT07201558Phase 1b/2 Study of IV Sarilumab in Adult With RA
- ClinRx Research - Plano- Site Number : 8400015, Plano
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT07704580A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/08/07更新 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Arlington, Arlington
- Artiva Investigational Site Bellaire, Bellaire
- Artiva Investigational Site Irving, Irving
- 他4件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT06991114Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
- Precision Comprehensive Clinical Research Solutions, Colleyville
- Rheumatology Associates, Dallas
- Precision Comprehensive Clinical Research Solutions, Irving
被験者募集中
18歳以上 · 全性別 · 2026/07/07更新 · NCT07293871A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- Research Site, Austin
- Research Site, Baytown
- Research Site, Houston
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/24更新 · NCT07276581R-2487 in Patients With Rheumatoid Arthritis
- Prolato Clinical Research Center, Houston
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/06/12更新 · NCT05961592Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/20更新 · NCT04751396A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中観察研究
18歳〜71歳 · 全性別 · 2026/04/16更新 · NCT07123038ConsideRAte Study - Splenic Stimulation for RA
- Arthritis & Rheumatology Institute, Allen
- St. David's Healthcare, Austin
- Tekton Research, Austin
- 他1件
被験者募集中
22歳〜75歳 · 全性別 · 2024/05/22更新 · NCT05003310ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。